Chen Rumei received her BSc with academic excellence scholarship from Nan Kai University, China. Upon graduation, she was conferred a full-time PhD research scholarship offered by the Yong Loo Lin School of Medicine in National University of Singapore, Singapore. Her research focus revolves around the profiling of an estrogen-regulated oncogene (TFF3) in CRC and the development of novel therapeutic strategies against it. Meanwhile she has been accredited by Experimental Therapeutics Centre & D3 in Singapore during a course that educate scientists about conducting translational R&D theory and practice. From which, she learnt many practical guidance to translate basic research findings into full-fledged R&D projects. Other than research, Chen has been active in promoting science-related events such as assisting to organize the International Union of Basic and Clinical Pharmacology world conference. She is a member of many international committees, such as European Association for Cancer Research, Pharmacological Society of Singapore.